Frovocimab

Tax included
Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody (mAb) that neutralizes PCSK9. Frovocimab inhibits PCSK9 binding to LDL receptor (LDLR) while permitting the normal proteolytic cleavage of the bound intact PCSK9.
MedChemExpress 
HY-P99626

Data sheet

Size
Multiple sizes
Reactivity
Ser/Thr Protease
Application
Metabolism-protein/nucleotide metabolism
CAS
1643672-70-1